Acute ischemic stroke treatment in 2007.
Goldstein
Larry B
LB
Department of Medicine (Neurology), Center for Cerebrovascular Disease, Duke University and Durham VA Medical Center, Durham, NC, USA. golds004@mc.duke.edu
D000208:Acute Disease; D000465:Algorithms; D000925:Anticoagulants / Q000627:therapeutic use; D002545:Brain Ischemia / Q000150:complications / Q000175:diagnosis / Q000534:rehabilitation / Q000628:therapy*; D002986:Clinical Trials as Topic; D019468:Disease Management; D005343:Fibrinolytic Agents / Q000627:therapeutic use; D006801:Humans; D018696:Neuroprotective Agents / Q000627:therapeutic use; D011994:Recombinant Proteins / Q000627:therapeutic use; D017131:Thrombectomy; D015912:Thrombolytic Therapy; D010959:Tissue Plasminogen Activator / Q000627:therapeutic use
D000925:Anticoagulants; D005343:Fibrinolytic Agents; D018696:Neuroprotective Agents; D011994:Recombinant Proteins; D010959:Tissue Plasminogen Activator